However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...

The U.S. Food and Drug Administration has asked a federal judge in Texas to throw out a public records lawsuit related to ...

The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a ...

A vaccine against fentanyl—yes! Finally, a truly novel approach to SUDs is currently under development and hopefully will ...

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...

The U.S. Food and Drug Administration has put a trial of Novavax’s COVID-influenza and its standalone flu vaccines on hold after a participant who took the combination shot reported nerve damage, the ...

And FDA said that Boston Scientific has again issued new instructions for its Obsidio Conformable Embolic after 15 injuries ...

Shares of US protein-based vaccine maker Novavax closed down 19.4% at $10.15 yesterday having dropped as much as 24%, on the ...

The Food and Drug Administration put clinical holds on Novavax's COVID-19 and flu combination vaccine and its standalone flu ...

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined ...